An efficient one-pot synthesis of novel 6-hydroxy-14-aryl-8H-dibenzo[a,i]xanthene-8,13(14H)-diones derived from lawsone

An efficient and convenient procedure for the synthesis of novel 6-hydroxy-14-aryl-8H-dibenzo[a,i]xanthene-8,13(14H)-dione derivatives has been developed by one-pot, three-component condensation reaction between 2-hydroxynaphthalene-1,4-dione, aromatic aldehydes and 2,3-naphthalenediol in glacial acetic acid under reflux conditions. This domino reaction implies Knoevenagel condensation, Michael addition, intramolecular cyclization and dehydration. The reaction avoids tedious workup procedure due to the direct precipitation of products from the reaction medium. The notable features of this domino transformation are operational simplicity, clean reaction, easy handling, easy purification process and high yields of the products.

Graphical abstract

     

Characterizing Local Rings via Test Modules

This article shows some instances where properties of a local ring are closely connected with the homological properties of a single module.     

Excellent photocatalytic reduction of nitroarenes to aminoarenes by BiVO4 nanoparticles grafted on reduced graphene oxide (rGO/BiVO4)

A novel heterogeneous composite material based on reduced graphene oxide (rGO) and bismuth vanadate (BiVO₄) was prepared and characterized by various techniques such as powder XRD, HRTEM, EADX, UV–Vis‐DRS, FT‐IR, Raman, BET and XPS analyses. The characterization results reveal that the rGO well decorated by BiVO₄. The electrochemical impedance spectroscopy (EIS) shows the increasing of charge transfer of rGO/BiVO₄ in presence of light irradiation. In this research, the pure BiVO₄ and rGO/BiVO₄ composite have been explored for photocatalytic reduction of nitroarenes. Among the prepared nanocomposites, rGO loaded with 10% BiVO₄ catalyst (noted as rGO/BiVO₄–10%) shows the best performance for the photo‐reduction of various nitroaromatic molecules to their corresponding amine compounds under visible‐light irradiation at room temperature. The catalyst exhibited in particular excellent photocatalytic activity for the conversion of 1,4‐dinitrobenzene to 4‐nitroanilline (100% conversion) in 20 min, 4‐chloronitrobenzene to 4‐chloroaniline and 2‐nitrophenol to 2‐aminophenol (100% conversion) in only 30 min. In addition, the conversion of 4‐bromonitrobenzene, 4‐iodonitrobenzene to their corresponding amine compounds (100% conversion) was achieved in 60 min. The catalyst was recovered for several times and reused without decreasing of its efficiency.     

Spectral and molecular docking studies of nucleic acids/protein binding interactions of a novel organometallic palladium (II) complex containing bioactive PTA ligands: Its synthesis,anticancer effects and encapsulation in albumin nanoparticles

The organometallic palladium complex with nitrogen-containing heterocycles is a potent antitumor agent. Coordination of phosphorus ligands to organometallic complexes increases their hydrophilicity, promotes ligand−DNA interactions and damage level to cancer cells, and blocks division in target cells. In this study, a phosphaadamantane palladium complex ([Pd{(C,N)- (C₁₂H₈NH₂)} (PTA) Cl], PTA = 1,3,5-Triaza-7-phosphaadamantane) ( 2 ) was synthesized via the reaction of biologically active PTA with binuclear palladacycles [Pd₂{(C,N)-(C₁₂H₈NH₂)}₂(μ-Cl)₂] ( 1 ). In vitro studies of the complex with DNA (calf-thymus) explored by UV–Vis, emission titration, circular dichroism and helix melting methods showed that the complex interacts with DNA via an intercalative mechanism. Furthermore, competitive binding studies using warfarin, digoxin and ibuprofen site markers containing definite binding sites revealed the binding of the complex to site I on bovine serum albumin. The in vitro release mechanism of the palladium complex exhibited a biphasic pattern characterized by an initial burst release followed by a slower sustained release. Ultimately, in vitro evaluation of cytotoxicity and cell death showed that the complexes were able to decrease the viability of human cancer cell lines (MCF-7 and Jurkat) in a dose-dependent manner, but lower decreases were observed in the viability of normal fibroblast cells ASF-4 at the dosages evaluated. Finally, the order of in vitro anticancer activities was found to be consistent with the DNA-binding affinities.